Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer [Phase 3]
Phase 3 clinical trial evaluating KC1036 versus investigator's choice chemotherapy in advanced esophageal squamous cell carcinoma is current…
-
CLINICAL_TRIALS withdrawal · 2024-02-13Clinical Trial Update: Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery [Phase 3]
A Phase 3 trial evaluating nutritional supplementation to reduce complications in locally advanced esophageal cancer undergoing chemo/radiat…
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating toripalimab in combination with neoadjuvant chemotherapy and chemoradiotherapy for locally advanced unresectable es…
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients [Phase 1, Phase 2]
Clinical trial update on immunotherapy with concurrent chemoradiotherapy followed by surgery for locally advanced esophageal squamous cell c…
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC [Phase 3]
Phase 3 trial evaluating a PD-1 antibody plus mXELIRI versus mXELIRI alone in second-line esophageal squamous cell carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial investigating anti-PD-L1 in combination with chemotherapy or chemoradiotherapy for resectable esophageal squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308) [Phase 3]
A Phase 3 trial evaluating neoadjuvant chemoradiotherapy with either docetaxel or vinorelbine plus cisplatin for esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma [Phase 2, Phase 3]
A phase 2/3 trial comparing postoperative concurrent chemoradiotherapy to radiotherapy alone in locoregionally advanced esophageal squamous …
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC [Phase 2]
Phase 2 trial evaluating anti-PD-1 immunotherapy in combination with SBRT for patients with oligometastatic esophageal squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial comparing tislelizumab versus chemotherapy as second-line treatment in advanced esophageal squamous cell carcinoma has complet…
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating extensive clinical target volumes in postoperative radiotherapy with concurrent chemotherapy for esophageal squamou…
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Postoperative Immune Maintenance Therapy for Esophageal Squamous Cell Carcinoma After Radical Resection [Phase 3]
A Phase 3 clinical trial update evaluating postoperative immune maintenance therapy for esophageal squamous cell carcinoma after radical res…
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: A Study of CS1001 in Subjects With Esophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial update for CS1001 in unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus [Phase 1]
Phase 1 trial evaluating preoperative anti-PD-1 antibody combined with chemoradiotherapy for locally advanced esophageal squamous cell carci…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Concurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma（EC-CRT-003） [Phase 2]
A Phase 2 clinical trial update for concurrent chemoradiotherapy in metastatic esophageal squamous cell carcinoma is underway, with status c…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial evaluating tislelizumab in combination with chemotherapy as first-line treatment for advanced esophageal squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 ) [Phase 3]
Phase 3 trial evaluating sintilimab plus chemotherapy versus placebo with chemotherapy in esophageal squamous cell carcinoma completed.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC) [Phase 2]
Phase 2 trial update investigating IBI110 with sintilimab for second-line advanced or metastatic esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Neoadjuvant Pembrolizumab Plus Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update on neoadjuvant pembrolizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma has c…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCC [Phase 1, Phase 2]
Clinical trial update for DV in combination with PD-1 and platinum-based first-line therapy in HER2 IHC 2+/3+ esophageal squamous cell carci…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating Cadonilimab plus Anlotinib in locally advanced or relapsed/metastatic esophageal squamous cell carcinoma a…
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Neoadjuvant Treatment of Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 neoadjuvant trial evaluating cadonilimab plus albumin-paclitaxel, cisplatin, and fluorouracil for resectable locally advanced esopha…
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab [Phase 1, Phase 2]
A Phase 1/2 trial evaluating letetresgene autoleucel (lete-cel) T-cells targeting NY-ESO-1/LAGE-1a, alone or with pembrolizumab, in advanced…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma [Phase 3]
Phase 3 clinical trial comparing 61.2 Gy versus 50.4 Gy radiotherapy dose for locally advanced esophageal carcinoma (esophageal squamous cel…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17) [Phase 2]
Phase II study evaluating postoperative concurrent chemoradiotherapy for esophageal squamous cell carcinoma (ESO-Shanghai 17) is active but …